Skip to main content

Table 1 Clinical data of colorectal cancer (CRC) patients

From: Promoter methylation correlates with reduced NDRG2expression in advanced colon tumour

  CRC
n = 30 (%)
Age (yrs):  
Mean (± SD) 59 ± 14
Sex:  
Male/Female 15/15
Tumour location:  
Ascending colon 7 (23%)
Transverse colon 2 (7%)
Descending colon 4 (13%)
Sigmoid colon 8 (27%)
Rectum 4 (13%)
Rectum-Sigmoid colon 5 (17%)
AJCC stage:  
0 1 (3%)
I 3 (10%)
IIa 8 (27%)
IIIb 3 (10%)
IIIc 1 (3%)
IV 14 (47%)
Age (yrs):  
Mean age <50 41 ± 7
CRC:  
Familiar/Sporadic 1/8
Tumour location:  
Ascending colon 1 (11%)
Descending colon 2 (22%)
Sigmoid colon 4 (45%)
Rectum 1 (11%)
Rectum-Sigmoid colon 1 (11%)
AJCC stage:  
I 1 (11%)
IIIb 2 (22%)
IIIc 1 (11%)
IV 5 (55%)
Age (yrs):  
Mean age >50 66 ± 9
CRC:  
Familiar/Sporadic 8/13
Tumour location:  
Ascending colon 6 (29%)
Transverse colon 2 (9%)
Descending colon 2 (9%)
Sigmoid colon 4 (19%)
Rectum 3 (15%)
Rectum-Sigmoid colon 4 (19%)
AJCC stage:  
0 1 (5%)
I 2 (9%)
IIa 8 (38%)
IIIb 1 (5%)
IV 9 (43%)